Intercept Pharmaceuticals, Inc(NASDAQ:ICPT) 
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. Its lead products candidate is the Ocaliva, a farnesoid X receptor agonist used for t...
Website: http://www.interceptpharma.com
Founded: 2002
IPO Price: $15 (Oct 11, 2012)
Full Time Employees: 583
CEO: Jerry Durso
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2023-05-12
P
O 15.70
H 16.42
L 15.51
C 15.89
V 576,777
10EMA 15.89
20EMA 15.89
60EMA 15.89
120EMA 15.89
250EMA 15.89